This is what FOMO-ing into China tech stocks looks like.
Source: Brian Tycangco 鄭彥渊 @BrianTycangco on X
Here's how Chinese stocks have done since they all told you that Chinese stocks were going to crash because of something they're calling "Tariffs"
Source: J-C Parets
Western Biotech’s “DeepSeek Moment” – China’s Rise in Pharma Innovation.
A WSJ artivcle >>> https://lnkd.in/eSua5PBt The WSJ article opens with how Summit Therapeutics’ cancer drug, licensed from China’s Akeso, outperformed Merck’s $30B Keytruda. But apparently this isn't all that special — Chinese companies now account for 31% of major pharma licensing deals, up from just 5% in 2020. Why Chinese Biotech Is Winning ✅ Lower costs & streamlined clinical trials ✅ Lean operations with minimal bureaucracy ✅ Better drug candidates at lower prices ✅ Faster R&D with Wuxi and other CDMOs driving efficiency Source: Rui Ma 马睿 on X, WSJ
BREAKING: Beginning Monday, China will implement tariffs of up to 15% on $14 billion in U.S. exports, including LNG, coal, crude oil, farm equipment, and select vehicles.
Looks like China is fighting back against Trump's 10% tariffs on Chinese imports that he announced last week... Source: Financial Times
China's retaliatory tariff will hit the United States today.
Here is how the U.S Corporations and consumers will be impacted. Source: Unicus @UnicusResearch
Xi’s Reply to Trump Tariffs Shows China Has More to Lose - Bloomberg
https://lnkd.in/ez4qCpZa Source: Bloomberg thru C.Barraud
BREAKING: China has opened antitrust investigations into Nvidia and Google just hours after imposing 10%-15% tariffs on some US imports, per FT.
China is reportedly looking for new trade war leverage against President Trump. Source: FT
Visualizing the Rise in Global Coal Consumption ⚡️
Source: Elements
